Terms: = Germ cell tumor AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
286 results:
1. CD133 significance in glioblastoma development: in silico and in vitro study.
Abdoli Shadbad M; Nejadi Orang F; Baradaran B
Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
[TBL] [Abstract] [Full Text] [Related]
2. Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice.
Delzenne G; Boileau M; Jamme P; Farchi O; Mortier L
Melanoma Res; 2024 Apr; 34(2):182-185. PubMed ID: 38329225
[TBL] [Abstract] [Full Text] [Related]
3. The role of craf in cancer progression: from molecular mechanisms to precision therapies.
Riaud M; Maxwell J; Soria-Bretones I; Dankner M; Li M; Rose AAN
Nat Rev Cancer; 2024 Feb; 24(2):105-122. PubMed ID: 38195917
[TBL] [Abstract] [Full Text] [Related]
4. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
5. Spitz tumor with raf1 fusion: A report of 3 cases.
Donati M; Nosek D; Olivares S; Lemahieu J; Loontiens S; Mansour B; Gerami P; Kazakov DV
Ann Diagn Pathol; 2023 Dec; 67():152215. PubMed ID: 37856952
[TBL] [Abstract] [Full Text] [Related]
6. A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [
Wollenberg L; Hahn E; Williams J; Litwiler K
Pharmacol Res Perspect; 2023 Oct; 11(5):e01140. PubMed ID: 37775918
[TBL] [Abstract] [Full Text] [Related]
7. miR-224-5p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway.
Liu Y; Ruan H; Lu F; Peng H; Luan W
Pathol Res Pract; 2023 Sep; 249():154772. PubMed ID: 37611431
[TBL] [Abstract] [Full Text] [Related]
8. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway.
Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399
[TBL] [Abstract] [Full Text] [Related]
9. Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.
Najem A; Krayem M; Sabbah S; Pesetti M; Journe F; Awada A; Désaubry L; Ghanem GE
Cells; 2023 Jul; 12(14):. PubMed ID: 37508519
[TBL] [Abstract] [Full Text] [Related]
10. Recurrent TRAK1::raf1 Fusions in pediatric low-grade gliomas.
Benhamida JK; Harmsen HJ; Ma D; William CM; Li BK; Villafania L; Sukhadia P; Mullaney KA; Dewan MC; Vakiani E; Karajannis MA; Snuderl M; Zagzag D; Ladanyi M; Rosenblum MK; Bale TA
Brain Pathol; 2023 Sep; 33(5):e13185. PubMed ID: 37399073
[TBL] [Abstract] [Full Text] [Related]
11. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
[TBL] [Abstract] [Full Text] [Related]
12. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract] [Full Text] [Related]
13. CircXPO1 Promotes Glioblastoma Malignancy by Sponging miR-7-5p.
Wang X; Wang J; An Z; Yang A; Qiu M; Tan Z
Cells; 2023 Mar; 12(6):. PubMed ID: 36980172
[TBL] [Abstract] [Full Text] [Related]
14. Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib.
Tkacik E; Li K; Gonzalez-Del Pino G; Ha BH; Vinals J; Park E; Beyett TS; Eck MJ
J Biol Chem; 2023 May; 299(5):104634. PubMed ID: 36963492
[TBL] [Abstract] [Full Text] [Related]
15. Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in
de Braud F; Dooms C; Heist RS; Lebbe C; Wermke M; Gazzah A; Schadendorf D; Rutkowski P; Wolf J; Ascierto PA; Gil-Bazo I; Kato S; Wolodarski M; McKean M; Muñoz Couselo E; Sebastian M; Santoro A; Cooke V; Manganelli L; Wan K; Gaur A; Kim J; Caponigro G; Couillebault XM; Evans H; Campbell CD; Basu S; Moschetta M; Daud A
J Clin Oncol; 2023 May; 41(14):2651-2660. PubMed ID: 36947734
[TBL] [Abstract] [Full Text] [Related]
16. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of craf and MEK1/2.
Wang P; Jia X; Lu B; Huang H; Liu J; Liu X; Wu Q; Hu Y; Li P; Wei H; Liu T; Zhao D; Zhang L; Tian X; Jiang Y; Qiao Y; Nie W; Ma X; Bai R; Peng C; Dong Z; Liu K
Signal Transduct Target Ther; 2023 Mar; 8(1):96. PubMed ID: 36872366
[TBL] [Abstract] [Full Text] [Related]
17. Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the raf1 gene.
Boileau M; Descarpentries C; Delzenne G; Trentesaux V; Greliak A; Jamme P; Marchetti P; Mortier L
Melanoma Res; 2023 Jun; 33(3):247-251. PubMed ID: 36866640
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of New Quinolone-Based Diarylamides as Potent B-RAF
Kim HJ; Park JW; Seo S; Cho KH; Alanazi MM; Bang EK; Keum G; El-Damasy AK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834628
[TBL] [Abstract] [Full Text] [Related]
19. Atypical Molecular Features of Pediatric Tectal Glioma: A Single Institutional Series.
Yakir MJ; Elster JD; Paul MR; Khanna PC; Malicki DM; Levy ML; Crawford JR
J Pediatr Hematol Oncol; 2023 Apr; 45(3):e410-e414. PubMed ID: 36730386
[TBL] [Abstract] [Full Text] [Related]
20. germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
[TBL] [Abstract] [Full Text] [Related]
[Next]
